Connect with us


Can psychedelic mushrooms trigger psychosis? 



In the hours leading up to my first magic mushroom experience, I was overwhelmed with conflicting thoughts. On the one hand, I was exhilarated by friends’ tales of wandering the woods in a state of psychedelic wonder and oneness. But on the other hand, there was also a sense of trepidation. Urban legends of people who have hit the mushies hard and never been the same again played over in my mind and made me wonder whether I should rethink the trip I’d planned. (I went ahead with it, but ended up microdosing.)

For a long time, hearsay, anecdotes, and your friend’s cousin’s brother were the go-to sources for magic mushroom information. Nowadays, psilocybin is making its way into high-profile clinical drug trials, and scientists are investigating its therapeutic versatility in treating various  mental health conditions, like depression and PTSD. As a result, we have more access to a diversity of reliable data on this psychedelic compound and its effects. 

But for many of us, an unnerving question remains: Is there even the slightest chance that psilocybin can make you go crazy?

Psilocybin, psilocin, and short-term psychosis

When a person consumes magic mushrooms, the main compound in them—psilocybin—is quickly converted by the body into psilocin, its active form. Psilocin is responsible for the psychedelic effects of shrooms and plays a major role in the trip that unfolds. However, in the same way that cannabis is composed of thousands of compounds, magic mushrooms contain a host of active compounds that may also shape and contribute to the psychedelic experience.

Although magic mushroom journeys are unique for everyone, they often share typical features. Those who consume a standard or medium dose of magic mushrooms (about 1.75 grams) often find that the effects kick in after 30-60 minutes; peak effects occur around the 1- to 2-hour mark; and the trip lasts from four to six hours, with a lingering afterglow in the hours or days that follow. 

During the journey, users can experience mood swings and intense emotions, mystical experiences, a warped sense of time, ego dissolution (a loss of one’s sense of self), confused thoughts, hallucinations, and delusions. 

However, delusions, hallucinations, and disorganized or confused thinking or speaking are also hallmark characteristics of psychosis and schizophrenia

Psychosis is a term that describes when an individual has lost contact with reality and is experiencing difficulty understanding what is real and what isn’t. Psychosis can be a symptom of a mental illness, such as schizophrenia or bipolar disorder (during depression and/or mania), but it can also be caused by sleep deprivation, an injury, a traumatic experience, certain prescription medications, or hallucinogenic substances—like psilocybin. 

In addition to hallucinations, delusions, and confused thinking, other symptoms of psychosis can include intense new ideas, strange feelings or no feelings at all, paranoid ideas, or difficulty concentrating. 


What are psychedelic mushrooms and psilocybin?

It’s important to understand that, in general, psychosis is considered a symptom, not a mental health condition (unlike schizophrenia). The duration of a psychotic episode depends on the cause. An episode that may be triggered by a substance, for example, typically has a short duration, lasting only while the substance is active in the person’s body. Psychotic episodes linked to a mental health condition such as schizophrenia, however, can last for days, months, or even longer. 

The parallels between the symptoms of psychosis, schizophrenia, and psilocybin journeys are well-known. Psilocybin has been used in clinical research to model psychosis, and the experiences that typically arise during a magic mushroom trip can look like a form of temporary psychosis.

“In some individuals, psilocybin can trigger short-term psychotic episodes during a trip,” explained Dr. Sam Zand, psychiatrist and Chief Medical Officer at Better U. Zand points out that although short-term psychosis may arise during a psilocybin trip and can feel frightening, it isn’t necessarily harmful.

“[It’s scary] because it involves losing touch with reality, which can be disorienting and distressing,” said Zand. “Additionally, the effects of psilocybin can include intense and confusing thoughts, feelings, and perceptions, which can also contribute to feelings of fear or anxiety. The unpredictability of the experience can also add to the fear, as the individual may not know what to expect and may feel out of control.” 

However, Zand emphasizes that it’s vital to remember that the effects of psilocybin are temporary, and they typically subside as the trip wears off.


How to dose psychedelic mushrooms

Can short-term psychosis be beneficial?

Although psilocybin can bring on challenging or frightening experiences, those experiences may in fact yield unique benefits.

“Individuals may have beneficial therapeutic effects despite a negative experience during the psilocybin experience,” explained Dr. Robert Alexander, Chief Medical Officer at Reunion Neuroscience. “However, it may be hard to keep one’s perspective when experiencing frightening illusions, the loss of ego boundaries or intense emotions.”

In one survey of almost 2,000 psilocybin mushroom users, researchers found that a psychologically difficult trip positively and significantly correlated to an experience of enhanced personal meaning, spiritual significance, and increased life satisfaction. In addition, 84% of participants believed that they had benefited from their challenging experience.

Other research stresses similar findings, with most participants reflecting that unpleasant experiences during bad trips had ultimately been beneficial, yielding deep existential and life-altering insights. Some psychedelic experts strongly believe that a temporary state of psychosis may enable the emergence of new perceptions and more flexible, creative ways of thinking. 

One researcher refers to psychosis as a double-edged sword: While the experience can feel immensely challenging, it may also be healing and life-changing. In this way, a temporary experience of psychosis during a psilocybin trip isn’t necessarily something to be avoided or feared. 


How long do magic mushrooms stay in your system?

Can psilocybin trigger long-term psychosis or schizophrenia, or exacerbate existing conditions?

Several 2022 systematic reviews have outlined the safety of psilocybin. The first, a review of studies investigating the use of psilocybin for psychiatric disorders, reported that there had been no significant adverse clinical events from psilocybin to date, and no verifiable recorded deaths. The second, a review of clinical studies exploring the therapeutic potential of psilocybin, found that psilocybin had a positive benefit-risk balance in the treatment of mental disorders and few serious adverse events reported. 

Dr. Alexander emphasizes that although short-term psychotic episodes can occur during a psilocybin trip, prolonged psychosis that persists for a day or longer is extremely rare. There are, however, several case studies that suggest that the compound could potentially (temporarily) worsen existing cases of schizophrenia or detrimentally affect individuals with existing mental health conditions.

In the first of these case studies, the individual had a history of schizophrenia and experienced severe mood swings, hallucinations, and delusions after consuming a handful of psilocybin mushrooms with cannabis twice daily. He was given an antipsychotic, and his symptoms improved over two weeks. 

In another case, a man with a 10-year history of paranoid schizophrenia experienced mood swings, hallucinations, paranoia, and compulsive thoughts after taking psilocybin mushrooms for an unspecified amount of time. However, his symptoms disappeared within days with no pharmacological treatment. 

While a few other cases exist, the limited data and confounding variables (such as the co-use of cannabis in the first case study) mean that it’s difficult to draw a definitive conclusion about the role psilocybin played in these episodes. 

Nonetheless, both Alexander and Zand recommend that people with current psychosis symptoms or a prior history of psychosis or schizophrenia may be at a higher risk of adverse effects and should therefore avoid psilocybin. 

“The importance of caution and consulting with a mental health professional before using any psychoactive substance cannot be stressed enough, especially for those with a history of mental health concerns,” said Zand.

It’s also crucial to consider whether psilocybin could detrimentally affect an individual with a family history or genetic predisposition toward schizophrenia or psychosis. Currently, there’s insufficient data, so many researchers and clinicians adopt a cautious approach and generally exclude people at high risk from participating in psychedelic therapy. 

“It’s unclear whether a positive family history of psychosis should be exclusionary [for taking psilocybin],” explained Dr. Alexander. “The concern is that the psychedelic could precipitate psychosis; there have been anecdotal reports of this happening with recreational LSD use, although it appears to be extremely rare in a therapeutic setting.”


Psychedelic medicine: The benefits of psychedelics

Tips for tripping with magic mushrooms

Drs. Alexander and Zand both emphasize that factors such as dosage, mindset, and setting can influence whether an individual experiences temporary psychosis during a psilocybin trip or not, and the subsequent nature of the experience.

Surveys suggest that the frequency of challenging experiences rises as the psilocybin dose increases. While this doesn’t mean higher doses should necessarily be avoided, it’s something to be aware of for those experimenting with psilocybin. Generally, a microdose is unlikely to kick off hallucinations, while a heroic dose will likely have you seeing, feeling, and hearing things that physically aren’t there.

“Dosage can play a significant role in the likelihood of experiencing psychosis,” explained Zand. “Higher doses of psilocybin can increase the risk of adverse effects, including short-term psychotic episodes. It’s important to follow proper dosing guidelines and start with low doses, especially for individuals who are new to psilocybin.” 

Having the right mindset and setting are other critical factors that can profoundly influence a psilocybin trip’s twists, turns, and ultimate outcome. In this context, mindset means approaching a psilocybin journey with an open, relaxed, and curious state of mind; setting means undertaking the journey in a comfortable and safe place, ideally with someone experienced holding space with you. This way, if you experience hallucinations or other uncomfortable feelings, they will be more manageable. 

According to Zand, “The importance of preparation, including setting a clear intention, creating a safe and supportive environment, and engaging in breathwork practices, cannot be overstated in reducing the risk of adverse effects and enhancing the therapeutic potential of the experience.”

Emma Stone's Bio Image

Emma Stone

Emma Stone is a journalist based in New Zealand specializing in cannabis, health, and well-being. She has a Ph.D. in sociology and has worked as a researcher and lecturer, but loves being a writer most of all. She would happily spend her days writing, reading, wandering outdoors, eating and swimming.

View Emma Stone’s articles

Source link

Continue Reading


Researchers say cannabis may help treat Covid-19




Researchers have been investigating cannabis as a possible treatment for Covid-19 since the pandemic began in 2020. They directed much of their attention towards cannabis’ ability to dampen the immune system and quell cytokine storms, a dangerous and potentially deadly immune response that occurs in severe Covid-19 cases and leads to respiratory distress and organ failure. Since then, scientists have identified a variety of ways cannabis might be helpful in fighting the disease.

Source link

Continue Reading


Medical pot patients’ lives improved during 1-year study




A recent study conducted by a group of UK-based researchers found that medical cannabis was associated with improvements in health-related quality of life, anxiety, and sleep quality. This research adds to the growing body of literature suggesting that medical cannabis can help patients with chronic health conditions improve their well-being. The study also observed a reduced use of opioid medications among cannabis patients, and found that patients prescribed dried cannabis flower (versus tinctures and lozenges) were most likely to show clinical improvement.

The complex and nuanced task of studying cannabis

The cannabis plant is an incredibly complex and variable medicine. It contains over 400 chemical compounds, more than 100 of which have known medical effects. These chemicals are present in different amounts and combinations in cannabis, depending on numerous factors: The particular strain, the way it was grown, the way it was processed, and the way it is consumed. 

The authors of this study took a different route: They studied the effects of specific regimens of medical cannabis and their effects on patients’ well-being.

When observational studies investigate cannabis use, they often capture results from a wide variety of different substances, not just cannabis. More controlled studies—there aren’t many—tend to focus on one or two isolated components of cannabis. While these studies provide more specific results, they don’t tell us much about how the various compounds interact with each other. This makes cannabis extremely challenging to study. 

The authors of this study, however, decided to take a different route: They studied the effects of specific regimens of medical cannabis and their effects on patients’ well-being. By keeping track of the particulars of the medical cannabis in question, they hoped to gather data that could give us more specific information about cannabis’ effects.  


The 7 most important cannabis research studies of 2023

Can cannabis improve quality of life? 

In this study, the researchers analyzed data from a cohort of 1,378 medical cannabis patients in the UK. About 40% of the patients were already consumers when the study began; the rest were not. 

These patients had been prescribed a variety of specific cannabis options, including inhaled dried flower, sublingual oils, or a combination of the two (based on the medical needs of the patient).

At the start of the study, researchers collected information about patients’ demographics, conditions, medications, and occupations, as well as their history with cannabis, other drugs, and alcohol. Patients’ primary reasons for using cannabis varied, but the most common reasons were chronic pain, neuropathic pain, fibromyalgia, and anxiety.  

The authors found statistically significant improvements from baseline on all measures—anxiety, sleep quality, and health-related quality of life—at each benchmark.

Once the study began, patients were given a variety of self-reporting assessments they could use to describe their health-related quality of life, anxiety, and sleep quality. The first assessment was given before patients began their cannabis regimen. Patients were given additional assessments 1, 3, 6, and 12 months into the program. 

After analyzing the data from the year-long study, the authors found statistically significant improvements from baseline on all measures—anxiety, sleep quality and health-related quality of life—at each benchmark. The data suggested that cannabis was benefiting these patients. 

Shop highly rated dispensaries near you

Showing you dispensaries near

See all dispensaries

Patients in the study who used opioid medications also reported reducing their opioid use during the study. The greatest reduction (5.66%) occurred after one year of cannabis use. 


DEA wants to boost production of cannabis and psychedelics research in 2023

Dried cannabis flower showed the biggest improvements

In an interesting twist, the study also found that patients prescribed dried cannabis flowers—rather than sublingual cannabis options, like tinctures or lozenges, alone—experienced more substantial improvements. Dried flowers are the raw form of cannabis, usually consumed by smoking or vaporizing. Sublinguals, on the other hand, are a more processed form of cannabis which can be absorbed through the mucosal membranes in the mouth. 

While patients who used both cannabis flowers and sublingual cannabis saw similar results to those using cannabis flowers alone, patients using solely sublinguals had less significant improvements. Those patients nonetheless saw improvements from baseline at each check-in. 

While roughly one-fifth of the patients did experience negative side effects from cannabis, the majority of those side effects were moderate or mild. Researchers observed that the most common side effects were fatigue, somnolence (excessive sleepiness), dry mouth, lethargy, and headache. One of the 1,378 patients experienced a single episode of psychosis. Lastly, the patients who were already using cannabis at the onset of the study demonstrated less negative side effects than those who had been abstinent.

We need more cannabis research

While this study provides valuable insight—and supports the idea that cannabis can improve our quality of life—it does have some limitations. As an observational study, it cannot prove that cannabis caused the improvements, only that a correlation exists. Additionally, since many patients were already cannabis consumers, the study may be biased towards them, since cannabis is evidently effective for them. Future research should include randomized and controlled double-blind studies. 

Source link

Continue Reading


Study: More older adults are using cannabis post-pandemic




Hunter Boyce | (TNS) The Atlanta Journal-Constitution

A new study, published in the Cannabis and Cannabinoids Research journal, found more older Americans are using cannabis today than before the pandemic. According to researchers with the University of Michigan’s Institute for Healthcare Policy and Innovation, roughly 1 in 8 Americans over 50 currently use the substance.

“As the stress of the pandemic and the increased legalization of cannabis by states converged, our findings suggest cannabis use increased among older adults nationally,” addiction psychologist and study lead Anne Fernandez told the University of Michigan.

Read the rest of this story on

Source link

Continue Reading


Copyright © 2021 The Art of MaryJane Media